The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Astrocytes in the initiation and progression of epilepsy
Open accessAbstract
Epilepsy affects ~65 million people worldwide. First-line treatment options include >20 antiseizure medications, but seizure control is not achieved in approximately one-third of patients. Antiseizure medications act primarily on neurons and can provide symptomatic control of seizures, but do not alter the onset and progression of epilepsy and can cause serious adverse effects. Therefore, medications with new cellular and molecular targets and mechanisms of action are needed. Accumulating evidence indicates that astrocytes are crucial to the pathophysiological mechanisms of epilepsy, raising the possibility that these cells could be novel therapeutic targets. In this Review, we discuss how dysregulation of key astrocyte functions - gliotransmission, cell metabolism and immune function - contribute to the development and progression of hyperexcitability in epilepsy. We consider strategies to mitigate astrocyte dysfunction in each of these areas, and provide an overview of how astrocyte activation states can be monitored in vivo not only to assess their contribution to disease but also to identify markers of disease processes and treatment effects. Improved understanding of the roles of astrocytes in epilepsy has the potential to lead to novel therapies to prevent the initiation and progression of epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In other contexts, such as acquired epilepsy, the presence of reactive astrocytes alone is sufficient to drive epileptogenesis54.”
From mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis (2026) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Bradley, S. J., Tobin, A. B., & Prihandoko, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.043 · Cited by 15
Harmonization in preclinical epilepsy research: A joint AES/ILAE translational initiative
Galanopoulou, A. S., French, J. A., O'Brien, T. J., & Simonato, M. (2017) · Epilepsia · doi:10.1111/epi.13921 · Cited by 14
Matsuo, N., Imamura, A., Ito, R., Sugawara, K., Takahashi, Y., & Kondo, N. (2007) · Neuropediatrics · doi:10.1055/s-2007-985368 · Cited by 13
Metabolic Changes in Early Poststatus Epilepticus Measured by MR Spectroscopy in Rats
Wu, Y. L., Pearce, P. S., Rapuano, A., Hitchens, T. K., de Lanerolle, N. C., & Pan, J. W. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.145 · Cited by 12
In Vivo Positron Emission Tomography Imaging of Adenosine A2A Receptors
Sun, M.-J., Liu, F., Zhao, Y., & Wu, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.599857 · Cited by 12
Neuroimaging biomarkers for epilepsy: Advances and relevance to glial cells
Obenaus, A. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.05.001 · Cited by 11
Elhady, M., Youness, E. R., AbuShady, M. M., Nassar, M. S., Elaziz, A. A., Masoud, M. M., Fouda, F. K., & Abuelhamd, W. A. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05136-5 · Cited by 7
Cited by
Sorted by citations
Perucca, E., Perucca, P., White, H. S., & Wirrell, E. C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00151-5 · Cited by 342
Specialized astrocytes mediate glutamatergic gliotransmission in the CNS
Ceglia, R. D., Ledonne, A., Litvin, D. G., Lind, B. L., Carriero, G., Latagliata, E. C., Bindocci, E., Castro, M. A. D., Savtchouk, I., Vitali, I., et al. (2023) · Nature · doi:10.1038/s41586-023-06502-w · Cited by 297
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
Self-citationRevolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes
Liao, J., Gong, L., Xu, Q., Wang, J., Yang, Y., Zhang, S., Dong, J., Lin, K., Liang, Z., Sun, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202402445 · Cited by 126
Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs
Sanz, P., Rubio, T., & García-Gimeno, M. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084161 · Cited by 118
Metadata
- Authors
- Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- University of Bonn (DE)
- Amsterdam Neuroscience (NL)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Vezzani, Annamaria
- ORCID
- Venue
- Nature Reviews Neurology
- Published
- 2022-10-24
- Volume
- 18
- Issue
- 12
- Pages
- 707-722
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC10368155
- OpenAlex
- W4307338781
- Cited by
- 272
- References
- 207
- Citations by year
- 2026: 82 · 2025: 96 · 2024: 53 · 2023: 41
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Funders
- Citizens United for Research in Epilepsy (NS065957, NS103740)
- ZonMw
- Bundesministerium für Bildung und Forschung (16GW0182, 01DN20001 CONNEX, 01DN20001, 16GW0182 CONNEXIN)
- Epilepsy Society
- National Institutes of Health (H2020, NS127846)
- Horizon 2020 Framework Programme (H2020-MSCA, 952455, 722053, H2020-MSCA-ITN)
- National Institute of Neurological Disorders and Stroke (R01NS061844, R01NS103740, R01NS065957, R01NS127846)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocytes, epilepsy, epileptogenesis, hyperexcitability, gliotransmission, astrocyte metabolism, astrocyte activation, antiepileptic drugs, novel therapeutic targets
- MeSH terms
- Astrocytes, Epilepsy, Humans, Neurons, Seizures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
